Peking University 1 Biomedical Pioneering Innovative Center (BIOPIC), Academy for Advanced Interdisciplinary Studies, School of Life Sciences, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer Beijing, China
Auto-generated profile, based on publicly available information
Wen Si
Peking University 1 Biomedical Pioneering Innovative Center (BIOPIC), Academy for Advanced Interdisciplinary Studies, School of Life Sciences, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer Beijing, China
An atlas of cancer-associated T cells: The tumor microenvironment contains many different kinds of immune cells, the composition, function, and roles of which are unclear. Using single-cell RNA sequencing of T cells in 21 cancer types from more than 300 patients, Zheng et al . identified differences in transcript composition that could be used to catalog different T cell types (see the Perspective by van der Leun and Schumacher). These annotations identified the different roles of specific types of CD4 + and CD8 + T cells among the different tumor types. Some of these clusters revealed evidence for two developmental paths for T cells, one of which shows a trajectory toward the “exhausted” T cell state, knowledge of which may be useful in developing future cancer immunotherapies. —LMZ
Cancer-associated fibroblasts (CAF) play a crucial role in shaping the tumor microenvironment and driving tumor progression. Although single-cell transcriptomics has revealed the phenotypic and functional heterogeneity of CAFs, effective therapeutic strategies targeting CAFs remain urgently needed. In this study, we identified LRRC15+ CAFs as a tumor-specific CAF subset in lung cancer and proposed LRRC15 as a potential therapeutic target. LRRC15 deficiency suppressed lung cancer progression in mice by modulating macrophage polarization and enhancing CD8+ T-cell activation. Mechanistically, LRRC15 deficiency inhibited CD206+ macrophage polarization by reducing extracellular matrix (ECM) production in CAFs, leading to increased CD8+ T-cell cytotoxicity. Finally, development of a bispecific antibody targeting LRRC15 and TGFβ enabled effective downregulation of LRRC15 expression in CAFs and limited tumor progression in mice. This study highlights LRRC15 as a promising therapeutic target and provides insights into CAF-directed cancer treatment strategies. Significance: LRRC15 in cancer-associated fibroblasts enhances extracellular matrix deposition, facilitates M2 macrophage polarization, and suppresses CD8+ T cell–mediated immunity, thereby promoting lung cancer progression and representing a potential therapeutic target.